Priovant Therapeutics, Inc.
Clinical trials sponsored by Priovant Therapeutics, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill could tame debilitating eye inflammation, major trial underway Results expected Sep 2026 (estimated)
-
Can a pill calm the skin symptoms of sarcoidosis?
Disease control Recruiting nowThis trial investigates whether an oral medication called brepocitinib can safely reduce skin lesions in adults with cutaneous sarcoidosis, a condition where inflammation causes bumps and rashes on the skin. Participants will receive either brepocitinib or a placebo to compare ef…
Phase 2/3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New pill could stop scalp scarring and hair loss
Disease control Recruiting nowThis study tests an oral medication called brepocitinib for adults with lichen planopilaris, a condition that causes scalp inflammation, scarring, and hair loss. About 342 participants will receive either the drug or a placebo to see if it reduces symptoms and improves scalp appe…
Phase 2/3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC